Reference9 articles.
1. Anti-epileptic drugs and hepatitis C therapy: real-world experience;Marcos-Fosch;J Hepatol,2021
2. EASL recommendations on treatment of hepatitis C: final update of the series;J Hepatol,2020
3. When coadministration cannot Be avoided: real world experience of direct acting antivirals for the treatment of hepatitis C virus infection in patients on first generation anticonvulsants;Natali;J Pharm Pract,2022
4. Quantification of second generation direct-acting antivirals daclatasvir, elbasvir, grazoprevir, ledipasvir, simeprevir, sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS;van Seyen;J Chromatogr B Analyt Technol Biomed Life Sci,2019
5. Pharmacokinetics and safety of velpatasvir and sofosbuvir/velpatasvir in subjects with hepatic impairment;Mogalian;Clin Pharmacokinet,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献